Currently Viewing:
Currently Reading
What We're Reading: Antibiotic of Last Resort; Soon-Shiong's Appointment; Stem Therapies in Texas
May 31, 2017 – AJMC Staff
FDA Urged to Keep Nutrition Facts Label on Schedule
May 30, 2017 – Mary Caffrey
What We're Reading: More Outcomes-Based Deals; Ebola Outbreak Small; Approving Expensive Drugs
May 29, 2017 – AJMC Staff
Overcoming Barriers to PCSK9 Prescriptions and Initial Denials
May 27, 2017 – Laura Joszt
Ahead of ASCO, Kite Pharma Announces Priority Review of Its CAR-T Treatment
May 26, 2017 – Surabhi Dangi-Garimella, PhD
A First: FDA Approves Pembrolizumab for Tissue-Agnostic Indication
May 23, 2017 – Surabhi Dangi-Garimella, PhD
Study Identifies Racial Disparity in Risk of Interval Colorectal Cancer
May 23, 2017 – Surabhi Dangi-Garimella, PhD
Multigene Testing Can Inform Predisposition to Inherited Prostate Cancer
May 22, 2017 – Surabhi Dangi-Garimella, PhD
Study Identifies Patterns of Peer Pressure With Advanced Imaging in Breast Cancer
May 19, 2017 – Surabhi Dangi-Garimella, PhD

What We're Reading: Antibiotic of Last Resort; Soon-Shiong's Appointment; Stem Therapies in Texas

AJMC Staff

Antibiotic of Last Resort Gets Modified

Vancomycin, the antibiotic of last resort, is getting modified to be more effective at fighting a dangerous hospital infection. CNN reported that some infections have become resistant even to vancomycin, so researchers modified the drug to work on bacteria in 3 ways, making it harder for bacteria to develop resistance. The modified drug still has to complete clinical trials before it can be mass produced, so it likely won’t be available for years.


Patrick Soon-Shiong Named to HHS Committee

Patrick Soon-Shiong will advise the Trump administration on health information technology (IT) as a new member of an HHS committee. House Speaker Paul Ryan named Soon-Shiong, a billionaire scientist, to the 25-member Health IT Advisory Committee that was authorized by the 21st Century Cures Act. According to Politico, there are questions about his conflicts of interest and how the expenditures of his nonprofit research organization have been spent.


Stem Cell Therapies in Texas

Texas could become the first state to recognize stem cell therapies, an experimental treatment for patients with chronic conditions or terminal illnesses. While clinics across the country have been offering the treatments for years, no state has legally validated them, according to STAT. The Texas measure would require the stem cell therapies be administered by a doctor at a hospital or ambulatory medical center. In addition, the treatment would have to be approved by an institutional review board and patients could sue if the treatment goes awry.

Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up